TY  - JOUR
DO  - 10.18773/austprescr.2025.024
IS  - 3
KW  - cardiovascular disease
cardiovascular risk
glucagon-like peptide-1
semaglutide
Wegovy
PY  - 2025
SN  - 1839-3942
SP  - 107-8
ST  - Semaglutide for cardiovascular risk reduction in people who are overweight or have obesity without diabetes (new indication)
T2  - Australian Prescriber
TI  - Semaglutide for cardiovascular risk reduction in people who are overweight or have obesity without diabetes (new indication)
UR  - https://australianprescriber.tg.org.au/articles/semaglutide-for-cardiovascular-risk-reduction-in-people-who-are-overweight-or-have-obesity-without-diabetes.html
VL  - 48
ID  - 1948
ER  -